Glanbia improving solubility of creatine monohydrate to tap sports nutrition market
By Katy Askew
- Last updated on
Glanbia Nutritionals will be debuting its CreaBev ingredient at FiE, featuring a patent pending encapsulation technology that facilitates a more soluble and stable creatine monohydrate.
With the global sports nutrition market valued at $20.3bn in 2018 according to Euromonitor, interest in ingredients like creatine monohydrate – itself valued at $100m – continues to rise. However, according to Glanbia Nutritionals, the issue with using standard creatine monohydrate in Ready-to-Drink (RTD) and Ready-to-Mix (RTM) formulations is that it has poor solubility in water and is unstable due to its degradation to waste product creatinine.
The company has created an ingredient that addresses both of these issues: CreaBev.
According to Glanbia Nutritionals, a recent study showed that in neutral pH RTD after three months approximately 95% of standard creatine monohydrate has already been converted to creatinine. After 12 months 100% has completely been degraded. This compares unfavourably to the performance of CreaBev. After 12 months, 70% of creatine monohydrate in CreaBev remained stable with only 30% degradation. Additionally, CreaBev does not crystalize when exposed to Ultra Heat Treatment or precipitate like standard forms of creatine monohydrate.
“With such superior stability and dispersion, CreaBev opens up new beverage formulation opportunities for manufacturers,” the company said noting that CreaBev will feature in the New Products Zone at FiE
“As ever we are excited to be back at FiE this year, and we are looking forward to introducing CreaBev to the European market,” said Tara Bane, European marketing manager at Glanbia Nutritionals.